gz389988
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2015 (NCT02424942)
Timeline
Indications
Studied for
Mechanism of action
- Nerve growth factor receptor Trk-AINHIBITOR
NTRK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gz389988
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02845271 | Phase 2 | Jul 1, 2016 | Genzyme, Sanofi |
| NCT02424942 | Phase 1 | Apr 1, 2015 | Genzyme, Sanofi |
Showing 2 of 2 trials
Page 1 / 1